HomeKTTA • NASDAQ
add
Pasithea Therapeutics Corp
Previous close
$6.80
Year range
$5.25 - $17.40
Market cap
7.05M USD
Avg Volume
2.21K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | — | — |
Net income | — | — |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 16.33M | -50.64% |
Total assets | 26.12M | -42.19% |
Total liabilities | 2.72M | 1.36% |
Total equity | 23.40M | — |
Shares outstanding | 1.04M | — |
Price to book | 0.30 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | — | — |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2020
Headquarters
Website
Employees
8